Clearmind Medicine (NASDAQ:CMND) Releases Earnings Results

Clearmind Medicine (NASDAQ:CMND) posted its earnings results on Wednesday. The company reported ($0.11) earnings per share (EPS) for the quarter, Zacks reports.

Clearmind Medicine Stock Performance

NASDAQ CMND traded down $0.02 on Friday, hitting $1.47. The stock had a trading volume of 7,496 shares, compared to its average volume of 233,105. Clearmind Medicine has a 52-week low of $0.95 and a 52-week high of $2.30. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.71 and a current ratio of 1.71. The firm has a 50-day moving average of $1.40 and a 200-day moving average of $1.41.

Clearmind Medicine Company Profile

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.